These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 8271378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H, Otaka A, Murakami T, Ishihara T, Ibuka T, Waki M, Matsumoto A, Yamamoto N, Fujii N.
    Biochem Biophys Res Commun; 1996 Feb 15; 219(2):555-9. PubMed ID: 8605026
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.
    Nakashima H, Masuda M, Murakami T, Koyanagi Y, Matsumoto A, Fujii N, Yamamoto N.
    Antimicrob Agents Chemother; 1992 Jun 15; 36(6):1249-55. PubMed ID: 1384424
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II).
    Masuda M, Nakashima H, Ueda T, Naba H, Ikoma R, Otaka A, Terakawa Y, Tamamura H, Ibuka T, Murakami T.
    Biochem Biophys Res Commun; 1992 Dec 15; 189(2):845-50. PubMed ID: 1472056
    [Abstract] [Full Text] [Related]

  • 8. Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.
    Jiang S, Lin K.
    Pept Res; 1995 Dec 15; 8(6):345-8. PubMed ID: 8838418
    [Abstract] [Full Text] [Related]

  • 9. An anti-HIV peptide, T22, forms a highly active complex with Zn(II).
    Tamamura H, Otaka A, Murakami T, Ibuka T, Sakano K, Waki M, Matsumoto A, Yamamoto N, Fujii N.
    Biochem Biophys Res Commun; 1996 Dec 13; 229(2):648-52. PubMed ID: 8954952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II).
    Otaka A, Tamamura H, Terakawa Y, Masuda M, Koide T, Murakami T, Nakashima H, Matsuzaki K, Miyajima K, Ibuka T.
    Biol Pharm Bull; 1994 Dec 13; 17(12):1669-72. PubMed ID: 7735216
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.
    Tamamura H, Murakami T, Horiuchi S, Sugihara K, Otaka A, Takada W, Ibuka T, Waki M, Yamamoto N, Fujii N.
    Chem Pharm Bull (Tokyo); 1995 May 13; 43(5):853-8. PubMed ID: 7553971
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NMR structure of mussel mytilin, and antiviral-antibacterial activities of derived synthetic peptides.
    Roch P, Yang Y, Toubiana M, Aumelas A.
    Dev Comp Immunol; 2008 May 13; 32(3):227-38. PubMed ID: 17628674
    [Abstract] [Full Text] [Related]

  • 17. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.
    Dettin M, Pasquato A, Scarinci C, Zanchetta M, De Rossi A, Di Bello C.
    J Med Chem; 2004 Jun 03; 47(12):3058-64. PubMed ID: 15163187
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [3'-Fluoro-deoxythymidine-5-fluorophosphate--an effective inhibitor of reproduction of human immunodeficiency virus in cell cultures].
    Arzumanov AA, Diatkina NB, Kukhanova MK, Kraevskiĭ AA, Semchenko FM, Eremin OG, Martynov BI.
    Bioorg Khim; 1993 Oct 03; 19(10):978-80. PubMed ID: 8274172
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.